Actually, they are recruiting for another phase 2 study: "Phase 2 Randomized Double-Blind Placebo-Controlled Multiple-Dose 3-Period Crossover Study to Compare a Fixed Dose Combination of AD816 to Viloxazine Alone and to Placebo in Obstructive Sleep Apnea"
https://clinicaltrials.gov/study/NCT05793684?term=apnimed&checkSpell=false&rank=1
Seems like the first phase 2 study didn't collect enough information to go into Pivotal studies.
Looks like INCANNEX is much more progressed
Add to My Watchlist
What is My Watchlist?